LifeVantage announces results of third-party cell study of health weight stack
LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer ...
Hosted on MSN1d
Craig-Hallum Initiates Coverage of LifeVantage (LFVN) with Buy Recommendation
Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy ...
LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - Buy
LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...
Hosted on MSN1d
LifeVantage initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Alex Fuhrman initiated coverage of LifeVantage (LFVN) with a Buy rating and $35 price target Discover ...
LifeVantage Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack*
LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...
Craig-Hallum bullish on LifeVantage, initiates with a Buy
As previously reported, Craig-Hallum initiated coverage of LifeVantage (LFVN) with a Buy rating and $35 price target Interest in weight loss ...
Nasdaq2d
LifeVantage Corporation Unveils Bold Vision for 2025 at Annual Global Kickoff Event
LifeVantage Corporation hosted its annual Global Kickoff on January 11, 2025, drawing thousands of independent Consultants to celebrate the company’s vision for the year, focusing on momentum ...
Top US Growth Stocks With Strong Insider Ownership
As the U.S. stock market navigates a mixed landscape with the S&P 500 inching higher and tech stocks experiencing volatility, investors are keenly observing growth companies with substantial insider ...
Wall Street Journal2d
Lifevantage Corp.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Seeking Alpha7d
LifeVantage soars after seeing a sales boost from its GLP-1 product
LifeVantage (NASDAQ:LFVN) soared in Wednesday trading after the company updated guidance earlier in the day. For FQ2, LifeVantage (NASDAQ:LFVN) sees revenue of $67.5 million vs. $51.5 million ...
Investing2d
LifeVantage expands health product suite, plans global rollout
SALT LAKE CITY - LifeVantage (NASDAQ:LFVN) Corporation (NASDAQ:LFVN), a company focused on nutrigenomics and wellness products with a market capitalization of $282 million, has announced the global ...
Investing2d
LifeVantage reports cellular health study results
SALT LAKE CITY - LifeVantage (NASDAQ:LFVN) Corporation (NASDAQ:LFVN), a company currently valued at $282 million with impressive gross profit margins of 79%, released a study today showing the ...